Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02408003Completed
Randomised trial in heart failure with preserved ejection fraction (HFpEF) and aortic valve stenosis comparing Levosimendan with Milrinone (2 arms). Primary endpoint: Change in diastolic strain rate. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02408003.